S. Svensson

发表

Radiosynthesis of the candidate β‐amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys

B. Gulyás, C. Halldin, K. Varnäs, 2010, Synapse.

Neurobiology of Disease Alzheimer's Disease: Presenilin 2-sparing ␥-secretase Inhibition Is a Tolerable A␤ Peptide-lowering Strategy

U. Lendahl, B. de Strooper, L. Serneels, 2022 .

The battle of Alzheimer’s Disease – the beginning of the future Unleashing the potential of academic discoveries

B. Winblad, G. Johansson, S. Svensson, 2014, Front. Pharmacol..

Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease

K. Blennow, H. Zetterberg, N. Mattsson, 2013, NeuroMolecular Medicine.

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184

Christer Halldin, Lars Farde, Katarina Varnäs, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β‐amyloid levels in the CNS

U. Lendahl, S. Eketjäll, A. Juréus, 2015, Journal of neurochemistry.

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

Lars Farde, Britt-Marie Swahn, Johan Sandell, 2010, Journal of neurochemistry.

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia

Colin L. Masters, Samuel Svensson, Zsolt Cselényi, 2013, The Journal of Nuclear Medicine.

Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand

Christer Halldin, Lars Farde, Katarina Varnäs, 2012, The Journal of Nuclear Medicine.

Synthesis, Radiolabeling, and In Vivo Pharmacokinetic Evaluation of the Amyloid Beta Radioligand [11C]AZD4694 in Nonhuman Primates

B. Gulyás, J. Sandell, C. Halldin, 2014, Molecular Imaging and Biology.

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients

Christer Halldin, Lars Farde, Katarina Varnäs, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹⁸F-PET imaging agents for β-amyloid plaques.

J. Sandell, P. Johnström, A. Juréus, 2012, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for beta-amyloid plaques.

J. Sandell, J. Malmström, A. Juréus, 2010, Bioorganic & medicinal chemistry letters.

AZD2184: a radioligand for sensitive detection of β‐amyloid deposits

Lars Farde, Johan Sandell, David Wensbo, 2009, Journal of neurochemistry.

Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R

G. Schellenberg, J. Hardy, A. Levey, 2020, Neurobiology of Disease.

Head-to-head comparison of 11C-PiB and 18F-AZD4694 for beta-amyloid imaging in aging and dementia

C. Rowe, C. Masters, R. Mulligan, 2012, Alzheimer's & Dementia.

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid

P. Svenningsson, W. Seeley, A. Boxer, 2016, Journal of Parkinson's disease.

Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies.

W. Klunk, C. Mathis, J. Sandell, 2021, ACS chemical neuroscience.

[11C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome

P. Svenningsson, L. Farde, V. Jelic, 2023, Synapse.

Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand

C. Halldin, K. Varnäs, A. Forsberg, 2012, The Journal of Nuclear Medicine.

An Auto-Catalytic Surface for Conformational Replication of Amyloid Fibrils—Genesis of an Amyloid World?

P. Tengvall, I. Lundström, S. Svensson, 2011, Origins of Life and Evolution of Biospheres.

A catalytic surface for amyloid fibril formation

P. Tengvall, I. Lundström, M. Ali, 2008 .